Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
Explore this paper's citation graph
Summary
Compared with aspirin, oral anticoagulant significantly decreases the risk of all strokes, ischemic strokes, and cardiovascular events for patients with nonvalvular chronic or paroxysmal AF but modestly increases the absolute risk of major bleeding.
- Type
- review
- Published
- 2002-11-20
- Cited by
- 762
- References
- 53
- OpenAlex
- https://openalex.org/W2045913143
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:25350605
Keywords
Medicine, Aspirin, Atrial fibrillation, Stroke (engine), Internal medicine
References
- Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.
- Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis.
- Atrial fibrillation and stroke. Three new studies, three remaining questions.
- Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?
- Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
- Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.
- Alternate-day dosing of aspirin in atrial fibrillation: A critical evaluation.
- Choice of antithrombotic therapy for stroke prevention in atrial fibrillation: warfarin, aspirin, or both?
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
- Warfarin Therapy for an Octogenarian Who Has Atrial Fibrillation
- Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin
- European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
- Methods for managing the increased workload in anticoagulant clinics
- Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group.
- The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life.
- Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.
- Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis.
- Warfarin for atrial fibrillation. The patient's perspective.
- Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
- Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation
Cited by
- The relationship between adherence and quality of treatment with vitamin K antagonists
- Characteristics of In-Hospital Onset Ischemic Stroke
- Cardioembolic Stroke in Atrial Fibrillation-Rationale for Preventive Closure of the Left Atrial Appendage
- Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study
- Atrial fibrillation and mortality: the impact of antithrombotic therapy.
- Treatment strategies for prevention of cardioembolic stroke in atrial fibrillation
- Atrial fibrillation and congestive heart failure.
- The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society
- Anticoagulation Therapy and NOACs in Heart Failure.
- Association between Embolic Stroke Patterns, ESUS Etiology, and New Diagnosis of Atrial Fibrillation: A Secondary Data Analysis of the Find-AF Trial
- An investigation of practice and practitioner factors that influence the recruitment of patients to primary care based randomised controlled trials: case study of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study
- Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
- Efectividad de la terapia antitrombótica en la prevención de eventos cerebro-vasculares en personas mayores de 65 años con fibrilación auricular
- How can we best detect atrial fibrillation?
- Adherence to treatment and anticoagulation control in vitamin K antagonists-treated patients: an administrative databases analysis in a large Italian population
- Electrophysiological Substrates of Atrial Fibrillation: A Frequency Domain Study of Intra-cardiac Electrograms
- Outcome of Stroke Prevention : Analyses Based on Data from Riks-Stroke and Other Swedish National Registers
- The psychological sequelae of transient ischaemic attack: the development of a preliminary screening tool
- Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.
- Atrial fibrillation: stroke prevention in older adults.
Related papers
- Warfarin and aspirin give more benefit than aspirin alone but also more bleeding after myocardial infarction
- The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.
- THE ROLE OF ASPIRIN AND WARFARIN IN IHD PREVENTION.
- Effect of plasma protein binding on the anticoagulant action of warfarin in rats.
- PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin.
- Anticoagulation with anisindione in patients who are intolerant of warfarin
- Predicting the Dose of Warfarin for Therapeutic Anticoagulation
- Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.
- Sex differences in the anticoagulant effects of warfarin.